Predict your next investment

ZEDIRA company logo
HEALTHCARE | Biotechnology
zedira.com

See what CB Insights has to offer

Founded Year

2007

Stage

Grant | Alive

Total Raised

$1.59M

Last Raised

$1.59M | 5 yrs ago

About ZEDIRA

Zedira, a biotech company located in Darmstadt, Germany, has made a commitment to Celiac Disease and Transglutaminase. The company's approach to the disorder is multifaceted. Research & Development: Celiac disease is a multi-system, multi-symptom disorder. The cause and mechanisms underlying the pathological response are not completely understood. In order to assist investigators studying celiac disease, Zedira will provide scientists worldwide with specialty reagents for basic research.

ZEDIRA Headquarter Location

Riedstrasse 7

64295,

Germany

Latest ZEDIRA News

Protein Glutamine Gamma Glutamyltransferase 2 Market Expected to Deliver Dynamic Progression until 2029 | Catabasis Pharmaceuticals Inc, Zedira GmbH

May 22, 2020

| Catabasis Pharmaceuticals Inc, Zedira GmbH New York City, NY: May 19, 2020, Published via (Wired Release) According to the latest report by Market.us Research, The Global Protein Glutamine Gamma Glutamyltransferase 2 Market Report study is also collected based on the latest and upcoming innovations, opportunities and trends. Protein Glutamine Gamma Glutamyltransferase 2 Market predicts that the overall demand growth will remain moderate all over the forecast period (2020-2029). The report also offers qualitative and quantitative research to deliver an entire and comprehensive analysis of the protein glutamine gamma glutamyltransferase 2 market Competition, Insights market. It is a detailed report concentrating on primary and secondary drivers, market share, leading sections, and geographical analysis. It is a combination of analytical research based on records, current, and forthcoming statistics and expected developments of the protein glutamine gamma glutamyltransferase 2 market. The research on various sectors including opportunities, volume, growth, technology, demand, and trend of high leading players has been examined. Request Exclusive Sample PDF Of Protein Glutamine Gamma Glutamyltransferase 2 Report Or you can directly buy this report At: https://market.us/request-covid-19/?report_id=36216 ***Note: The sample of this report is available upon request. Please use a corporate email ID to Get Higher Priority. **** The Aim of Protein Glutamine Gamma Glutamyltransferase 2 Market report is to present a complete assessment of the market and contains thoughtful insights, facts, actual data, industry-validated market data and predictions with a proper set of hypotheses and methodology. The report also analyses global businesses including growth trends, industry opportunities, investment strategies, and expert conclusions. This report focuses on the global key players ( Zedira GmbH and Catabasis Pharmaceuticals Inc) performing at a global level, to explain, define and analyze the multiple aspects of the protein glutamine gamma glutamyltransferase 2 market. Consult/speak with an expert for more detailed information on Protein Glutamine Gamma Glutamyltransferase 2 Market: https://market.us/report/protein-glutamine-gamma-glutamyltransferase-2-market/#inquiry ***Note: Please use a corporate email ID to Get Higher Priority. **** Know More About Protein Glutamine Gamma Glutamyltransferase 2 Report: Global Protein Glutamine Gamma Glutamyltransferase 2 Market report explains market segment such as product type, application, end-users, and region are presented in the report.Protein Glutamine Gamma Glutamyltransferase 2 the market report concentrates on several key regions: Japan, Europe (United Kingdom, Colombia and the rest of L.A.), United Arab Emirates and South Africa Rest of the Middle East), India, ASEAN, Mexico), France, Middle East and Africa (Turkey, Argentina, Latin America (Brazil, Germany, Asia Pacific (China, GCC, South Korea, Rest of Asia Pacific), Italy and rest of Europe), Canada, North America (USA and Spain.Protein Glutamine Gamma Glutamyltransferase 2 Market by product type segment is classified into (CAT-5571, ERW-1041E, ZED-1227), the application (Hospital, Clinic) segment, this report focuses on the status and outlook for key applications. The plans mainly include innovative product development, analysis, and development, and also presents revenue shares, business overview, and recent company developments to remain competitive in the market. Key Highlights of This Report: * Protein Glutamine Gamma Glutamyltransferase 2 Market growth has driven factor analysis. * growth opportunities available in the Protein Glutamine Gamma Glutamyltransferase 2 Market. * The complete evaluation of the vendor landscape and leading companies to assist get the level of competition. * Emerging recess segments and region-wise Protein Glutamine Gamma Glutamyltransferase 2 Market. * An empirical evaluation of the curve of the Protein Glutamine Gamma Glutamyltransferase 2 Market. * Past, Present, and Probable expanse of the market from both prospect value and volume. * Protein Glutamine Gamma Glutamyltransferase 2 Market report grants exclusive graphics and sample SWOT analysis. Some of the Major Highlights of TOC covers 1. Introduction 8. Appendix List of Figures About Us: Market.US specializes in in-depth market research and analysis and has been proving its mettle as a consulting and customized market research company, apart from being a much sought-after syndicated market research report providing firm. Market.US provides customization to suit any specific or unique requirement and tailor-makes reports as per request. We go beyond boundaries to take analytics, analysis, study, and outlook to newer heights and broader horizons. We offer tactical and strategic support, which enables our esteemed clients to make well-informed business decisions and chart out future plans and attain success every single time. Besides analysis and scenarios, we provide insights into global, regional, and country-level information and data, to ensure nothing remains hidden in any target market. Our team of tried and tested individuals continues to break barriers in the field of market research as we forge forward with a new and ever-expanding focus on emerging markets. Get in Touch with Us : Mr. Benni Johnson

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing ZEDIRA

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

ZEDIRA is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

5,238 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

ZEDIRA Patents

ZEDIRA has filed 6 patents.

The 3 most popular patent topics include:

  • Anticoagulants
  • Autoimmune diseases
  • Cardiac arrhythmia
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/2/2018

7/27/2021

Inflammations, Autoimmune diseases, Rare diseases, Lactams, Immune system

Grant

Application Date

1/2/2018

Grant Date

7/27/2021

Title

Related Topics

Inflammations, Autoimmune diseases, Rare diseases, Lactams, Immune system

Status

Grant

ZEDIRA Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

ZEDIRA Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.